Tuesday, July 11, 2017 2:08:45 PM
Maximum. In the ABSOLUTE best case scenario over 10. HOWEVER this would be contingent upon success in the clinic for SOLID TUMORS using the TriKE platform. Listen to the interview in the link below. Dr. Jeffery Miller, says the holy grail not just for TriKE but for any platform is solid tumors. Solid tumors make up a little over 75% of cancer. And so that means should their be success in the clinic for solid tumors. That the TriKE platform could be used for multiple different types of cancers and also leukemia. DON'T COUNT ON THIS HAPPENING THOUGH THIS IS VERY UNLIKELY TO HAPPEN
https://player.fm/series/chi-podcasts/pegs-boston-2017-generation-of-bikes-and-trikes
In terms of what I think the company will be acquired for? I think what will happen is the same thing is what happened with the new ceos previous company Chase. Oxis will be acquired before any of its drug have finished their trials for 500 million. However, assuming continued success in the trials, That amount could easily exceed 2 billion upon achieving certain milestones. (I.E moving into phase 3 potentially a royalty off sales once the drug is approved)
Finally, I'm going to assume a 1 for 100 reverse split. I believe once they publicly announce data from the OXS-1550, oxis share price will reach 10 cents a share. At this price they will do a reverse split up list to the nasdaq and do an ipo at $10 a share. Averse a reverse split there will be 4 million shares outstanding, and by the time the company is acquired there will be 60 million. (Additional selling of shares needed to fund the continuing trials and to compensate management.)
Here's the good news, thank God Cataldo is gone, the new management will not allow 750 million outstanding shares. I am sure Dr. Kathleen has no interest in running a penny stock. And once she officially becomes ceo, she will up list the company right away.
Sorry didn't answer this earlier thought all there was was (I agree with you!)
Recent GTBP News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:05:21 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/17/2024 08:26:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:25:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/24/2024 12:31:08 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/23/2024 10:04:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 10:02:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:00:40 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:46:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 05:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 08:30:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 10:00:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:25:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2023 10:23:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/06/2023 10:21:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 01:00:37 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/27/2023 09:23:48 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM